# Generate Biomedicines (GENB) — Overview

GENB · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/genb

## Price

Last close $13.06 on Oct 15, 2026. 52-week range $11.21 – $20.38.

## Company profile

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $26.5M |
| Revenue (quarter) | $6.3M |
| Revenue growth (year over year) | -37.67% |
| Gross profit (trailing twelve months) | $26.5M |
| Gross margin | 100.00% |
| Net income (trailing twelve months) | −$250.9M |
| Net income (quarter) | −$67.3M |
| Net income growth (year over year) | -18.53% |
| Net margin | -947.32% |
| Return on equity | 0.00% |
| EPS (trailing twelve months) | −$5.41 |
| Book value per share | $3.56 |
| P/E (trailing twelve months) | — |
| Price to book | 3.7 |
| Debt to assets | 18.81% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Generate Biomedicines (GENB) profitable?

No. Generate Biomedicines reported a net loss of $250.9M over the trailing twelve months.

### How much revenue does Generate Biomedicines (GENB) make?

Generate Biomedicines generated $26.5M in revenue over the trailing twelve months, down 37.67% year over year.

### How do I buy stock in Generate Biomedicines (GENB)?

GENB trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).